Morpheus RealTime Ultrasound, Pathway RealTime Ultrasound, QuickScan Bladder Ultrasound

{0}------------------------------------------------ Image /page/0/Picture/1 description: The image shows the logo for the Department of Health & Human Services - USA. The logo features a stylized representation of a human figure with three faces in profile, stacked on top of each other. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the figure. Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002 April 15, 2016 The Prometheus Group % Mr. Joshua Bird Senior Software Engineer 1 Washington Street. Suite 303 DOVER NH 03820 Re: K160792 Trade/Device Name: Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, QuickScan® Bladder Ultrasound Regulation Number: 21 CFR 892.1560 Regulation Name: Ultrasonic pulsed echo imaging system Regulatory Class: II Product Code: IYO, ITX Dated: March 25, 2016 Received: March 29, 2016 Dear Mr. Bird: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. {1}------------------------------------------------ If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638 2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Sincerely yours, Michael D'Hara For Robert Ochs, Ph.D. Director Division of Radiological Health Office of In Vitro Diagnostics and Radiological Health Center for Devices and Radiological Health Enclosure {2}------------------------------------------------ #### DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration ### Indications for Use Form Approved: OMB No. 0910-0120 Expiration Date: January 31, 2017 See PRA Statement below. 510(k) Number (if known) K160792 Device Name Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, QuickScan® Bladder Ultrasound Indications for Use (Describe) Morpheus® RealTime Ultrasound, Pathway® RealTime Utrasound, QuickScan® Bladder Ultrasound are diagnostic ultrasound systems designed to be used for general pelvic imaging. An ultrasonographic crystal within the probe records images of the organ, muscle, and tissue structures of the pelvic region. Measurements and calculations of the organ, muscle, and tissue structures can be recorded. Type of Use (Select one or both, as applicable) |X Prescription Use (Part 21 CFR 801 Subpart D) Over-The-Counter Use (21 CFR 801 Subpart C) #### CONTINUE ON A SEPARATE PAGE IF NEEDED. This section applies only to requirements of the Paperwork Reduction Act of 1995. #### *DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.* The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to: > Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov "An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number." {3}------------------------------------------------ ## Diagnostic Ultrasound Indications for Use The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime System: Ultrasound, QuickScan® Bladder Ultrasound Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | Clinical Application | | Mode of Operation | | | | | | | | |---------------------------|------------------------------------|-------------------|---|-----|-----|------------------|-----------------------|---------------------|--| | General<br>(Track 1 Only) | Specific<br>(Tracks 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Combined<br>(Specify) | Other*<br>(Specify) | | | Ophthalmic | Ophthalmic | | | | | | | | | | | Fetal | | | | | | | | | | Fetal Imaging &<br>Other | Abdominal | N | | | | | | Note 1 | | | | Intra-operative (Specify) | | | | | | | | | | | Intra-operative (Neuro) | | | | | | | | | | | Laparoscopic | | | | | | | | | | | Pediatric | | | | | | | | | | | Small Organ (Specify) | N | | | | | | Note 2<br>Note 3 | | | | Neonatal Cephalic | | | | | | | | | | | Adult Cephalic | | | | | | | | | | | Trans-rectal | N | | | | | | Note 3 | | | | Trans-vaginal | N | | | | | | Note 3 | | | | Trans-urethral | | | | | | | | | | | Trans-esoph. (non-Card.) | | | | | | | | | | | Musculo-skeletal<br>(Conventional) | | | | | | | | | | | Musculo-skeletal<br>(Superficial) | | | | | | | | | | | Intravascular | | | | | | | | | | | Other (Specify) | | | | | | | | | | | Cardiac Adult | | | | | | | | | | Cardiac | Cardiac Pediatric | | | | | | | | | | | Intravascular (Cardiac) | | | | | | | | | | | Trans-esoph. (Cardiac) | | | | | | | | | | | Intra-cardiac | | | | | | | | | | | Other (Specify) | | | | | | | | | | Peripheral | Peripheral vessel | | | | | | | | | | Vessel | Other (Specify) | | | | | | | | | N = new indication Note 1: Abdominal - Pelvic, Solid Organs, Aneurysms, Bladder Note 2: Small Organ - Testes, Prostate Note 3: Includes imaging for guidance of biopsy. ∑ Prescriptive Use (Part 21 CFR 801.109) {4}------------------------------------------------ ## Diagnostic Ultrasound Indications for Use The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime System: Ultrasound, QuickScan® Bladder Ultrasound Transducer: GP 3.5 MHz / AB 3.5 MHz Mechanical Sector Probe Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | Clinical Application | | Mode of Operation | | | | | | | |---------------------------|------------------------------------|-------------------|---|-----|-----|------------------|-----------------------|---------------------| | General<br>(Track 1 Only) | Specific<br>(Tracks 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Combined<br>(Specify) | Other*<br>(Specify) | | Ophthalmic | Ophthalmic | | | | | | | | | | Fetal | | | | | | | | | Fetal Imaging &<br>Other | Abdominal | P | | | | | | Note 1 | | | Intra-operative (Specify) | | | | | | | | | | Intra-operative (Neuro) | | | | | | | | | | Laparoscopic | | | | | | | | | | Pediatric | | | | | | | | | | Small Organ (Specify) | P | | | | | | Note 2 | | | Neonatal Cephalic | | | | | | | | | | Adult Cephalic | | | | | | | | | | Trans-rectal | | | | | | | | | | Trans-vaginal | | | | | | | | | | Trans-urethral | | | | | | | | | | Trans-esoph. (non-Card.) | | | | | | | | | | Musculo-skeletal<br>(Conventional) | | | | | | | | | | Musculo-skeletal<br>(Superficial) | | | | | | | | | | Intravascular | | | | | | | | | | Other (Specify) | | | | | | | | | Cardiac | Cardiac Adult | | | | | | | | | | Cardiac Pediatric | | | | | | | | | | Intravascular (Cardiac) | | | | | | | | | | Trans-esoph. (Cardiac) | | | | | | | | | | Intra-cardiac | | | | | | | | | | Other (Specify) | | | | | | | | | Peripheral | Peripheral vessel | | | | | | | | | Vessel | Other (Specify) | | | | | | | | P = previously cleared by FDA, K070907 Note 1: Abdominal - Pelvic, Solid Organs, Aneurysms, Bladder Note 2: Small Organ - Testes, Prostate 2 Prescriptive Use (Part 21 CFR 801.109) {5}------------------------------------------------ ## Diagnostic Ultrasound Indications for Use The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime System: Ultrasound, QuickScan® Bladder Ultrasound ER 12 MHz / ES 12 MHz Mechanical Sector Probe Transducer: Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | Clinical Application | | Mode of Operation | | | | | | | | |---------------------------|------------------------------------|-------------------|---|-----|-----|------------------|-----------------------|---------------------|--| | General<br>(Track 1 Only) | Specific<br>(Tracks 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Combined<br>(Specify) | Other*<br>(Specify) | | | Ophthalmic | Ophthalmic | | | | | | | | | | | Fetal | | | | | | | | | | Fetal Imaging &<br>Other | Abdominal | | | | | | | | | | | Intra-operative (Specify) | | | | | | | | | | | Intra-operative (Neuro) | | | | | | | | | | | Laparoscopic | | | | | | | | | | | Pediatric | | | | | | | | | | | Small Organ (Specify) | | | | | | | | | | | Neonatal Cephalic | | | | | | | | | | | Adult Cephalic | | | | | | | | | | | Trans-rectal | P | | | | | | | | | | Trans-vaginal | | | | | | | | | | | Trans-urethral | | | | | | | | | | | Trans-esoph. (non-Card.) | | | | | | | | | | | Musculo-skeletal<br>(Conventional) | | | | | | | | | | | Musculo-skeletal<br>(Superficial) | | | | | | | | | | | Intravascular | | | | | | | | | | | Other (Specify) | | | | | | | | | | Cardiac | Cardiac Adult | | | | | | | | | | | Cardiac Pediatric | | | | | | | | | | | Intravascular (Cardiac) | | | | | | | | | | | Trans-esoph. (Cardiac) | | | | | | | | | | | Intra-cardiac | | | | | | | | | | | Other (Specify) | | | | | | | | | | Peripheral | Peripheral vessel | | | | | | | | | | Vessel | Other (Specify) | | | | | | | | | P = previously cleared by FDA, K070907 Z Prescriptive Use (Part 21 CFR 801.109) {6}------------------------------------------------ ## Diagnostic Ultrasound Indications for Use The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime System: Ultrasound, QuickScan® Bladder Ultrasound EC 7.5 MHz / EB 7.5 MHz Mechanical Sector Probe Transducer: Intended Use: Diagnostic ultrasound imaging or fluid flow analysis of the human body as follows: | Clinical Application | | Mode of Operation | | | | | | | |---------------------------|------------------------------------|-------------------|---|-----|-----|------------------|-----------------------|--------| | General<br>(Track 1 Only) | Specific<br>(Tracks 1 & 3) | B | M | PWD | CWD | Color<br>Doppler | Combined<br>(Specify) | | | Ophthalmic | Ophthalmic | | | | | | | | | Fetal Imaging &<br>Other | Fetal | | | | | | | | | | Abdominal | | | | | | | | | | Intra-operative (Specify) | | | | | | | | | | Intra-operative (Neuro) | | | | | | | | | | Laparoscopic | | | | | | | | | | Pediatric | | | | | | | | | | Small Organ (Specify) | | | | | | | | | | Neonatal Cephalic | | | | | | | | | | Adult Cephalic | | | | | | | | | | Trans-rectal | P | | | | | | | | | Trans-vaginal | P | | | | | | Note 3 | | | Trans-urethral | | | | | | | | | | Trans-esoph. (non-Card.) | | | | | | | | | | Musculo-skeletal<br>(Conventional) | | | | | | | | | | Musculo-skeletal<br>(Superficial) | | | | | | | | | | Intravascular | | | | | | | | | | Other (Specify) | | | | | | | | | Cardiac | Cardiac Adult | | | | | | | | | | Cardiac Pediatric | | | | | | | | | | Intravascular (Cardiac) | | | | | | | | | | Trans-esoph. (Cardiac) | | | | | | | | | | Intra-cardiac | | | | | | | | | | Other (Specify) | | | | | | | | | Peripheral | Peripheral vessel | | | | | | | | | Vessel | Other (Specify) | | | | | | | | P = previously cleared by FDA, K070907 Note 3: Includes imaging for guidance of biopsy. X Prescriptive Use (Part 21 CFR 801.109) {7}------------------------------------------------ # 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS This summary of safety and effectiveness is provided as part of this Premarket Notification in compliance with 21 CFR, Part 807, Subpart E, Section 807.92. ## Submitter's name, address, telephone number, contact person: The Prometheus Group® 1 Washington Street Suite 303 Dover, NH 03820 Joshua Bird Senior Software Engineer Telephone: (603) 749-0733 Fax: (603) 749-0511 Email: jbird@theprogrp.com Prepared February 26, 2016 ## Name of the device, including the trade or proprietary name if applicable, the common or usual name, and the classification name, if known: Common/Usual Name: Diagnostic Ultrasound System and Accessories ## Proprietary Name: The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound ### Classification Names: | CFR Number | Product Code | | |---------------------------------------|--------------|--------| | Ultrasound Pulsed Echo Imaging System | 892.1560 | 90-IYO | | Diagnostic Ultrasound Transducer | 892.1570 | 90-ITX | {8}------------------------------------------------ ### Predicate Device: Device Name: Interson USB Ultrasound Probe System Manufacturer: Interson Corporation ### 510(k) Number: ### K070907 The Prometheus Group® believes that Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound are substantially equivalent to the currently marketed Interson USB Ultrasound Probe System. The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound have the same technological characteristics, safety and effectiveness features, comparable intended uses, and basic operating modes. ### Device Description: The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound utilize the ultrasound probes, cable and host software application used in Interson USB Ultrasound Probe System. The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound are a self contained portable, multiplemode, and multiple-application ultrasound imaging system. The system contains an ultrasound generator/receiver, analog to digital converter, microcontroller, control logic, USB 2.0 interface and control offering a full complement of conventional operating modes, software-based parameter controls, and video recording. User-customized parameter settings for the Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound may be inserted by the operator and stored for recall as needed via the system control panel. Customization includes transmit power, images controls selection, and Time Gain Compensation (TGC). Controls are also provided to select display format and to utilize the cine function. {9}------------------------------------------------ Patient contact materials have been used in accordance to their intended use and are described below for each individual transducers were previously cleared for use on other Systems (K070907). The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound are a B-Mode ultrasound scanner, which provides high resolution, high penetration performance. Probes are supported in frequencies from 2.5 MHz to 12.0 MHz. The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound provides various measuring functions. It can measure distances and calculate areas, circumferences and volumes, and calculate angles. The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound supports the Cine function (capable of storing up to 512 sequential images). Management of patient history is possible by image-storage function. High-resolution images are provided by utilizing a technology called digital dynamic receive focusing. The same clinical uses were cleared for the predicate device Interson USB Ultrasound Probe System, K070907. The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound interfaces with the Interson USB Ultrasound Probe System software to collect the ultrasound images, measurements, and calculations. The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound allows for the entry of patient information and generates reports from the recorded ultrasound images, measurements, and calculations. ### Morpheus® RealTime Ultrasound The Prometheus Group® Morpheus® RealTime Ultrasound allows the user to select up to 10 ultrasound images from an exam to include in the report. Additionally the user can input notes on the exam which are also included in the report. The report is formatted to be printed on standard 8 1/2" X 11" paper. {10}------------------------------------------------ ## Pathway® RealTime Ultrasound The Prometheus Group® Morpheus® RealTime Ultrasound allows the user to select up to 10 ultrasound images from an exam to include in the report. Additionally the user can input notes on the exam which are also included in the report. The report is formatted to be printed on standard 8 1/2" X 11" paper. ## QuickScan® Bladder Ultrasound The Prometheus Group® QuickScan® Bladder Ultrasound generates a condensed report containing a single image with the measurements and calculations recorded during the exam. The report is formatted to be printed on 80 mm thermal printer paper. ## Indications for Use: The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, QuickScan® Bladder Ultrasound are diagnostic ultrasound systems designed to be used for general pelvic imaging. An ultrasonographic crystal within the probe records images of the organ, muscle, and tissue structures of the pelvic region. Measurements and calculations of the organ, muscle, and tissue structures can be recorded. {11}------------------------------------------------ ## 510(k) Premarket Notification The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, QuickScan® Bladder Ultrasound | Technological<br>Characteristics | | Subject Device:<br>The Prometheus Group®<br>Morpheus® RealTime<br>Ultrasound | Subject Device:<br>The Prometheus Group®<br>Pathway® RealTime<br>Ultrasound | Subject Device:<br>The Prometheus Group®<br>QuickScan® Bladder<br>Ultrasound | Predicate Device:<br>Interson USB Ultrasound<br>Probe System (K070907) | |------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------| | Materials | Lens | TPX brand Polymethyle<br>Pentene (PMP) | TPX brand Polymethyle<br>Pentene (PMP) | TPX brand Polymethyle<br>Pentene (PMP) | TPX brand Polymethyle<br>Pentene (PMP) | | | Housing | Ertalyte brand<br>Polyetheylene<br>Terephthalate (PET-P),<br>Delrin | Ertalyte brand<br>Polyetheylene<br>Terephthalate (PET-P),<br>Delrin | Ertalyte brand<br>Polyetheylene<br>Terephthalate (PET-P),<br>Delrin | Ertalyte brand<br>Polyetheylene<br>Terephthalate (PET-P),<br>Delrin | | Measurements | | Distance (mm),<br>Circumference (mm), Area<br>(mm²), Angle (degree) | Distance (mm),<br>Circumference (mm), Area<br>(mm²), Angle (degree) | Distance (mm),<br>Circumference (mm), Area<br>(mm²), Angle (degree) | Distance (mm),<br>Circumference (mm), Area<br>(mm²), Angle (degree) | | Report | | Multiple page report<br>displaying up to 10 user<br>selectable images. The<br>report also displays notes<br>entered into the system by<br>the user. Printed on<br>standard 8 1/2" X 11"<br>paper. | Multiple page report<br>displaying up to 10 user<br>selectable images. The<br>report also displays notes<br>entered into the system by<br>the user. Printed on<br>standard 8 1/2" X 11"<br>paper. | Single page report<br>displaying a single image.<br>Printed on 80mm thermal<br>printer paper. | Single page report<br>displaying the first four<br>saved images. Printed on<br>standard 8 1/2" X 11"<br>paper. | | Principle Operation | | Apply high voltage bursts to<br>Piezoelectric material in the<br>transducer and detect the<br>reflected echo to construct<br>2D images for diagnostic<br>purposes. | Apply high voltage bursts to<br>Piezoelectric material in the<br>transducer and detect the<br>reflected echo to construct<br>2D images for diagnostic<br>purposes. | Apply high voltage bursts to<br>Piezoelectric material in the<br>transducer and detect the<br>reflected echo to construct<br>2D images for diagnostic<br>purposes. | Apply high voltage bursts to<br>Piezoelectric material in the<br>transducer and detect the<br>reflected echo to construct<br>2D images for diagnostic<br>purposes. | | Technological<br>Characteristics | Subject Device:<br>The Prometheus Group®<br>Morpheus® RealTime<br>Ultrasound | Subject Device:<br>The Prometheus Group®<br>Pathway® RealTime<br>Ultrasound | Subject Device:<br>The Prometheus Group®<br>QuickScan® Bladder<br>Ultrasound | Predicate Device:<br>Interson USB Ultrasound<br>Probe System (K070907) | | | Transducer Probe<br>Design | Mechanical sector<br>ultrasound imaging probe<br>that connects directly to<br>host computer via Universal<br>Serial Bus (USB). Host<br>computer forms real-time<br>ultrasonic images of human<br>tissue without need for<br>additional electronics,<br>power supplies, or support<br>devices of any kind. | Mechanical sector<br>ultrasound imaging probe<br>that connects directly to<br>host computer via Universal<br>Serial Bus (USB). Host<br>computer forms real-time<br>ultrasonic images of human<br>tissue without need for<br>additional electronics,<br>power supplies, or support<br>devices of any kind. | Mechanical sector<br>ultrasound imaging probe<br>that connects directly to<br>host computer via Universal<br>Serial Bus (USB). Host<br>computer forms real-time<br>ultrasonic images of human<br>tissue without need for<br>additional electronics,<br>power supplies, or support<br>devices of any kind. | Mechanical sector<br>ultrasound imaging probe<br>that connects directly to<br>host computer via Universal<br>Serial Bus (USB). Host<br>computer forms real-time<br>ultrasonic images of human<br>tissue without need for<br>additional electronics,<br>power supplies, or support<br>devices of any kind. | | | Acoustic Output<br>Limits:<br>All Applications | 'SPTA.3 94 mW/cm² (Max)<br>MI 1.9 (Max) | 'SPTA.3 94 mW/cm² (Max)<br>MI<br>1.9 (Max) | 'SPTA.3 94 mW/cm² (Max)<br>MI 1.9 (Max) | 'SPTA.3 94 mW/cm² (Max)<br>MI 1.9 (Max) | | | Clinical Applications | Abdomen<br>OB/GYN<br>Urology | Abdomen<br>OB/GYN<br>Urology | Abdomen<br>OB/GYN<br>Urology | Abdomen<br>OB/GYN<br>Urology<br>Cardiac<br>Fetal Heart<br>Vascular<br>Pediatric<br>Neonatal Cephalic<br>Opthalmology<br>Extremity | | {12}------------------------------------------------ {13}------------------------------------------------ The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound utilize the ultrasound probes, cable, and host software application, which were previously cleared under K070907. These devices operate identically to the predicate devices in that piezoelectric material in the transducer is used as an ultrasound source to transmit sound waves into the body. Sound waves are reflected back to the transducer and converted to electrical signals that are processed and displayed as a 2D images. The technological differences in clinical applications indicated for The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound systems versus those indicated for the Interson USB Ultrasound Probe System do not raise concerns for the safety and effectiveness of the device because the clinical applications indicated for The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound systems are a subset of the clinical applications indicated for the Interson USB Ultrasound Probe System. The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound system does not indicate any clinical applications outside of those indicated for the Interson USB Ultrasound Probe System. Additionally the clinical applications indicated for The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound are independent of the clinical applications not indicated. ## Morpheus® RealTime Ultrasound The technological differences in the report The Prometheus Group® Morpheus® RealTime Ultrasound do not raise concerns for the safety and effectiveness of the device because the images and data displayed in The Prometheus Group® Morpheus® RealTime Ultrasound report would also be displayed in the Interson USB Ultrasound Probe System report. The ability to include more images and user notes on the exam in the report by The Prometheus Group® Morpheus® RealTime Ultrasound increase the effectiveness of the report by allowing the user to provide more evidence to substantiate the findings of the exam. {14}------------------------------------------------ ### Pathway® RealTime Ultrasound The technological differences in the report The Prometheus Group® Pathway® RealTime Ultrasound do not raise concerns for the safety and effectiveness of the device because the images and data displayed in The Prometheus Group® Pathway® RealTime Ultrasound report would also be displayed in the Interson USB Ultrasound Probe System report. The ability to include more images and user notes on the exam in the report by The Prometheus Group® Pathway® RealTime Ultrasound increase the effectiveness of the report by allowing the user to provide more evidence to substantiate the findings of the exam. ## QuickScan® Bladder Ultrasound The technological differences in the report The Prometheus Group® QuickScan® Bladder Ultrasound do not raise concerns for the safety and effectiveness of the device because the images and data displayed in The Prometheus Group® QuickScan® Bladder Ultrasound report would also be displayed in the Interson USB Ultrasound Probe System report. The ability to include more images and user notes on the exam in the report by The Prometheus Group® QuickScan® Bladder Ultrasound would provide the same evidence to substantiate the findings as the Interson USB Ultrasound Probe System. ## Nonclinical Tests and Standards Used: The nonclinical tests performed on the Interson USB Ultrasound Probe System for clearance under 510(k) K070907 are applicable to The Prometheus Group® Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound as the Interson USB Ultrasound Probe System has not been modified by The Prometheus Group®. ## Clinical Tests: The Prometheus Group® Morpheus® RealTime Ultrasound. Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound did not require clinical studies to support substantial equivalence. {15}------------------------------------------------ ## Conclusion: The Prometheus Group® considers the Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound devices to be as safe and effective as the predicate device. The performance of the subject device is substantially equivalent to the predicate device. Intended uses and other key features are consistent with traditional clinical practice, FDA quidelines, and established methods of patient examination. The design and development process of the manufacturer conforms with medical device industry standards. The device conforms to applicable medical device safety standards and compliance is verified through independent evaluation. Diagnostic ultrasound has accumulated a long history of safe and effective performance. Therefore, it is the opinion of The Prometheus Group® that the Morpheus® RealTime Ultrasound, Pathway® RealTime Ultrasound, and QuickScan® Bladder Ultrasound are substantially equivalent with respect to safety and effectiveness to devices currently cleared for market.